Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1999
10/28/1999DE19818563A1 Reducing appetite and body weight, especially for treating obesity, by administration of alpha-lipoic acid
10/28/1999DE19818044A1 Reducing side effects or neutralizing action of carcinostatic or immunosuppressive agents, especially pyridine derivatives, using vitamin PP compounds, e.g. nicotinamide
10/28/1999CA2329660A1 Inhibitors of neuraminidases
10/28/1999CA2329637A1 (alpha-aminophosphino) peptidesderivative and compositions containing same
10/28/1999CA2329626A1 Cannabinoids as antioxidants and neuroprotectants
10/28/1999CA2329624A1 Pharmaceutical composition for neurotrophic action
10/28/1999CA2329422A1 Pyrrolidines as inhibitors of neuraminidases
10/28/1999CA2329413A1 2,3-olefinic epothilone derivatives
10/28/1999CA2329008A1 Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease)
10/28/1999CA2328962A1 Btk inhibitors and methods for their identification and use
10/28/1999CA2328949A1 Adhesive preparations
10/28/1999CA2328896A1 Treatment of generalized anxiety disorder with paroxetine
10/28/1999CA2328882A1 Pharmaceutical aerosol formulation
10/28/1999CA2328876A1 Novel 2-heterocyclically substituted dihydropyrimidines
10/28/1999CA2328875A1 Substituted 2-oxo-alkanoic acid-[2-(indol-3-yl)-ethyl] amides
10/28/1999CA2328733A1 The use of dihydropyrimidines as medicaments, and novel substances
10/28/1999CA2328720A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
10/28/1999CA2328435A1 New substituted amides, their production and their use
10/28/1999CA2328430A1 Substituted benzamides, their production and their use as cysteine protease inhibitors
10/28/1999CA2328413A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
10/28/1999CA2328364A1 Production of furanones
10/28/1999CA2328357A1 Therapeutic agent for primary biliary cirrhosis
10/28/1999CA2328331A1 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
10/28/1999CA2328264A1 Novel asymmetrically substituted xanthine derivatives, method for producing them and their use as medicaments with an adenosine-antagonistic effect
10/28/1999CA2328081A1 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor
10/28/1999CA2326823A1 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
10/28/1999CA2325864A1 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy
10/28/1999CA2325821A1 Antisense oligonucleotides for the inhibition of integrin .alpha.v-subunit expression
10/28/1999CA2325553A1 Topical formulations for the treatment of nail fungal diseases
10/28/1999CA2325391A1 Dermatophagoides nucleic acid molecules, proteins and uses thereof
10/28/1999CA2324995A1 Methods and products related to metabolic interactions in disease
10/28/1999CA2323609A1 12,13-cyclopropane epothilone derivatives
10/28/1999CA2323606A1 Bicyclic compounds having an anti-thrombitic effect
10/28/1999CA2322759A1 Novel diphenyl-substituted 6-ring-heterocycles, methods for producing them and their use as medicaments
10/27/1999EP0952224A2 Method for producing transgenic cucumber that produces high levels of superoxide dismutase
10/27/1999EP0952220A2 Method to predict active growth of bacteria adhered to a surface
10/27/1999EP0952218A2 Single chain, multiple antigen-binding molecule, its preparation and use
10/27/1999EP0952213A2 Process for inducing an immune response mediated by NK-cells
10/27/1999EP0952159A2 Use of somatostatin derivatives and/or of phenylhydrazone derivatives as antinflammatory or analgetic agents
10/27/1999EP0952157A1 9A, 11B-Dehydro derivatives of 9-oxime-3-keto-6-0-methylerythromycin
10/27/1999EP0952154A2 N-acyl and N-aroyl aralkyl amides
10/27/1999EP0952151A2 Intermediates for use in preparing novel pyridonecarboxylic acid derivatives or their salts
10/27/1999EP0952149A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors
10/27/1999EP0952148A1 Cyclobutyl-aryloxyarylsulfonylamino hydroxamic acid derivatives
10/27/1999EP0951915A2 System and method for providing a sterile medical solution containing glucose orglucose-like compounds
10/27/1999EP0951909A1 Combination composition comprising a L-carnitine or an alkanoyl-L-carnitine, a glycosaminoglycan and/or constituent thereof
10/27/1999EP0951908A2 Method of treating impotence due to spinal cord injury
10/27/1999EP0951907A1 Use of moxonidine as a thermogenesis stimulating agent
10/27/1999EP0951906A1 Use of 3,6-dimethyl-2-(2,4,6-trimethylphenoxy)-pyridines for treating heart failure
10/27/1999EP0951905A2 Pharmaceutical compositions for programmed therapeutical coverage
10/27/1999EP0951904A2 Agent for enhancing dermal microcirculation
10/27/1999EP0951903A1 Therapeutic treatment for renal dysfunction
10/27/1999EP0951842A2 Infant formula
10/27/1999EP0951568A1 Methods for detecting and inhibiting the rna component of telomerase
10/27/1999EP0951556A2 Disease associated protein tyrosine phosphatases
10/27/1999EP0951554A1 Fusion protein comprising the whole or part of the pp65 protein of human cmv, useable in particular for preparing a vaccine
10/27/1999EP0951540A2 Antisense nucleic acids and hammerhead ribozymes
10/27/1999EP0951536A1 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
10/27/1999EP0951481A1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis
10/27/1999EP0951480A1 Method and novel compounds for use therein
10/27/1999EP0951469A1 Novel compounds
10/27/1999EP0951467A1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE
10/27/1999EP0951466A2 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
10/27/1999EP0951465A1 Alpha-amino acid amides, preparation thereof and the therapeutical use thereof
10/27/1999EP0951464A1 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
10/27/1999EP0951300A1 Processes for spray drying solutions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
10/27/1999EP0951296A1 NOVEL FtsL
10/27/1999EP0951295A1 Methods and compositions useful for inhibition of angiogenesis
10/27/1999EP0951293A1 Method for treating alzheimer's disease
10/27/1999EP0951292A1 Methods for treating an ischemic disorder and improving stroke outcome
10/27/1999EP0951288A1 Reactive oxygen intermediates containing compounds effective in inducing cell differentiation of malignant cells such as leukemia
10/27/1999EP0951287A2 Oral composition comprising 5-aminosalicyclic acid
10/27/1999EP0951286A2 Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations
10/27/1999EP0951285A1 Inhibitors of farnesyl-protein transferase
10/27/1999EP0951284A1 Phenylethylamine derivatives
10/27/1999EP0951283A1 Novel arachidonic acid metabolite, 16-hete
10/27/1999EP0951282A1 Prevention and treatment of skeletal disorder with ep2 receptor subtype selective prostaglandin e2 agonists
10/27/1999EP0951281A2 2-CYCLOPENTEN-1-ONE AND ITS DERIVATIVES AS INHIBITORS OF THE NF-kappa B FACTOR
10/27/1999EP0951279A1 Tablet for the controlled release of active agents
10/27/1999EP0951278A2 Sustained release cisapride mini-tablet formulation
10/27/1999EP0936916A4 Cosmetic compositions
10/27/1999EP0825856A4 Irritation relief using nonsteroidal anti-inflammatory compounds
10/27/1999EP0641785B1 Triazolylated tertiary amine compound or salt thereof
10/27/1999EP0617616B1 Potentiation of nmda antagonists
10/27/1999EP0590082B1 Antisense oligonucleotide inhibition of the ras gene
10/27/1999EP0584088B1 Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
10/27/1999EP0544907B1 Antibacterial penem esters derivatives
10/27/1999EP0539525B1 Vitaletheine and use in cell culture and therapy
10/27/1999CN1233256A Dipeptide benzamidine as a kininogenase inhibitor
10/27/1999CN1233254A Purine L-nucleosides, analogs and uses thereof
10/27/1999CN1233249A Spiro(cyclopent [B] indole-piperidines) and N-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and MAO inhibitors
10/27/1999CN1233248A 1H-pyrido [3,4-b] indole-4-carboxamide derivatives, preparation and application thereof in therapeutics
10/27/1999CN1233247A Thio acid derived monocyclic N-heterocyclics as anticoagulants
10/27/1999CN1233246A Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors
10/27/1999CN1233245A Oxadiazoles, processes for their preparation and their use as medicaments
10/27/1999CN1233243A Crystalline form of 4-[5-methyl-3-phenylisoxazol)-4-yl] benzenesulfonamide
10/27/1999CN1233241A Propionic acid derivatives and applications thereof
10/27/1999CN1233238A Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
10/27/1999CN1233237A Heteroaryl succinamides and their use as metalloproteinase inhibitors
10/27/1999CN1233189A Treatment of asthma with TNFR-Ig
1 ... 6422 6423 6424 6425 6426 6427 6428 6429 6430 6431 6432 6433 6434 6435 6436 6437 6438 6439 6440 6441 6442 ... 7860